Table 4.
Cox proportional hazards regression analysis for CVD risk: quartile analysis
| Index | Quartile | HR (95% CI) | P-value |
|---|---|---|---|
| CVAI | Q1 | Ref. | |
| Q2 | 1.23 (1.02–1.48) | 0.031 | |
| Q3 | 1.35 (1.12–1.62) | 0.002 | |
| Q4 | 1.41 (1.17–1.70) | < 0.001 | |
| CTI | Q1 | Ref. | |
| Q2 | 1.16 (0.97–1.39) | 0.108 | |
| Q3 | 1.26 (1.06–1.51) | 0.010 | |
| Q4 | 1.34 (1.12–1.61) | 0.002 | |
| BMI | Q1 | Ref. | |
| Q2 | 1.04 (0.87–1.24) | 0.692 | |
| Q3 | 1.03 (0.86–1.23) | 0.770 | |
| Q4 | 1.41 (1.19–1.69) | < 0.001 | |
| WHtR | Q1 | Ref. | |
| Q2 | 1.14 (0.95–1.36) | 0.162 | |
| Q3 | 1.15 (0.96–1.37) | 0.143 | |
| Q4 | 1.39 (1.16–1.67) | < 0.001 | |
| ABSI | Q1 | Ref. | |
| Q2 | 1.26 (1.06–1.51) | 0.010 | |
| Q3 | 1.22 (1.02–1.45) | 0.030 | |
| Q4 | 1.21 (1.01–1.45) | 0.043 | |
| BRI | Q1 | Ref. | |
| Q2 | 1.14 (0.95–1.36) | 0.162 | |
| Q3 | 1.15 (0.96–1.37) | 0.143 | |
| Q4 | 1.39 (1.16–1.67) | < 0.001 | |
| CI | Q1 | Ref. | |
| Q2 | 1.09 (0.91–1.31) | 0.334 | |
| Q3 | 1.12 (0.94–1.34) | 0.222 | |
| Q4 | 1.29 (1.09–1.54) | 0.004 | |
| TyG | Q1 | Ref. | |
| Q2 | 1.14 (0.96–1.36) | 0.137 | |
| Q3 | 1.20 (1.01–1.43) | 0.039 | |
| Q4 | 1.13 (0.95–1.35) | 0.168 | |
| TyG-BMI | Q1 | Ref. | |
| Q2 | 1.22 (1.02–1.46) | 0.029 | |
| Q3 | 1.27 (1.06–1.52) | 0.010 | |
| Q4 | 1.50 (1.25–1.80) | < 0.001 | |
| TyG-WC | Q1 | Ref. | |
| Q2 | 1.18 (0.98–1.41) | 0.076 | |
| Q3 | 1.33 (1.12–1.59) | 0.001 | |
| Q4 | 1.42 (1.19–1.70) | < 0.001 | |
| TyG-WHtR | Q1 | Ref. | |
| Q2 | 1.19 (0.99–1.42) | 0.059 | |
| Q3 | 1.11 (0.93–1.34) | 0.247 | |
| Q4 | 1.36 (1.14–1.64) | 0.001 | |
| VAI | Q1 | Ref. | |
| Q2 | 1.11 (0.93–1.33) | 0.247 | |
| Q3 | 1.36 (1.14–1.63) | 0.001 | |
| Q4 | 1.21 (1.01–1.45) | 0.044 | |
| LAP | Q1 | Ref. | |
| Q2 | 1.09 (0.91–1.31) | 0.363 | |
| Q3 | 1.37 (1.15–1.64) | 0.001 | |
| Q4 | 1.36 (1.13–1.64) | 0.001 | |
| AIP | Q1 | Ref. | |
| Q2 | 1.05 (0.88–1.25) | 0.614 | |
| Q3 | 1.28 (1.08–1.52) | 0.004 | |
| Q4 | 1.13 (0.95–1.35) | 0.156 | |
| RC | Q1 | Ref. | |
| Q2 | 1.02 (0.85–1.21) | 0.850 | |
| Q3 | 1.17 (0.99–1.39) | 0.065 | |
| Q4 | 1.12 (0.95–1.33) | 0.183 | |
| NHDL | Q1 | Ref. | |
| Q2 | 1.10 (0.92–1.31) | 0.298 | |
| Q3 | 1.21 (1.02–1.43) | 0.032 | |
| Q4 | 1.20 (1.01–1.43) | 0.039 |
Notes: Results are from Model 3 adjusted for age, gender, marital status, education, residence, smoking, drinking, hypertension, diabetes mellitus, dyslipidemia, creatinine, and CRP. Q1 serves as the reference group. HR, hazard ratio; CI, confidence interval. CVAI, Chinese visceral adiposity index; CTI, C-reactive protein-triglyceride glucose index; BMI, body mass index; WHTR, waist-to-height ratio; ABSI, A body shape index; BRI, body roundness index; CI, conicity index; TyG, triglyceride glucose index; VAI, visceral adiposity index; LAP, lipid accumulation product; AIP, atherogenic index of plasma; RC, remnant cholesterol; NHDL, non-high-density lipoprotein cholesterol